None listed
Conditions
Interventions
None listed
Sponsors
Konkuk University Medical Center
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: - Age 45 to 80 years old. - Individuals who have agreed to participate in the clinical trial and voluntarily signed the written informed consent form. - Patients who clinically correspond to the normal aging group or patients who meet the clinical diagnostic criteria for Mild Cognitive Impairment according to the 2011 NIA-AA (National Institute on Aging-Alzheimer's Association) guidelines. - Primarily, patients who have undergone an amyloid PET scan, if possible, are the primary targets.
Exclusion criteria
Exclusion criteria: Exclusion criteria include individuals with a history of drug addiction, past or current neurological, psychiatric, neurosurgical diseases, or head trauma. Those who have taken psychiatric medications at doses higher than the therapeutic range that could affect brain waves in the past three months are also excluded. The study targets only individuals found to be free from dementia, based on a medical history survey, neurological examination, and cognitive function test conducted by a neurology specialist.
Design outcomes
Secondary
| Measure | Time frame |
|---|---|
| Temporal changes in susceptibility (brain iron) and BBB permeability. | — |
Primary
| Measure | Time frame |
|---|---|
| susceptiblity (brain iron), BBB permeability | — |
Countries
Korea, Republic of
Contacts
Public ContactWon Jin Moon
Konkuk University
Outcome results
None listed